Loading insider details...
Latest Form 4 (Sep 25, 2026): Exercise/Conversion of 11,969 PHVS shares, $96.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Pharvaris N.V. (PHVS) | Exercise/Conversion | 11,969 | $96.4K |
| Jun 3, 2026 | ADC Therapeutics SA (ADCT) | Grant/Award | 45,000 | n/a |
| May 26, 2026 | Pharvaris N.V. (PHVS) | Sale | 9,667 | $292.9K |
| Jun 17, 2025 | ADC Therapeutics SA (ADCT) | Tax Withholding | 2,584 | $9.3K |
| Jun 5, 2025 | ADC Therapeutics SA (ADCT) | Grant/Award | 40,000 | n/a |
| Jun 19, 2024 | ADC Therapeutics SA (ADCT) | Sale | 1,437 | $4.2K |
| Jun 14, 2024 | ADC Therapeutics SA (ADCT) | Grant/Award | 40,000 | n/a |
| Jun 11, 2021 | DBV Technologies S.A. (DBVT) | Purchase | 5,000 | $35.6K |